Brief: Inspira Announces 95% Accuracy Results For Hyla Blood Sensor And Plans FDA Submission For Clearance In 2024
26/12/2023 13:49
Dec 26 (Reuters) - Inspira Technologies Oxy BHN Ltd
IINN.O :
* INSPIRA™ ANNOUNCES 95% ACCURACY RESULTS FOR HYLA™ BLOOD
SENSOR,
PLANNING FDA SUBMISSION FOR CLEARANCE IN 2024
Source text for Eikon: ID:nPn2D29j6a
Further company coverage: IINN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Qtrex Quantum
See all newsBrief: Qtrex Announces Receipt Of Nasdaq Notification Regarding Minimum Bid Price Requirement
Brief: Qtrex Quantum Ltd In Discussions With A US Department Of Defense’S Research Laboratory To Establish A Joint Quantum Development Program
Brief: Qtrex Quantum - Offers Up To 6.8 Million Ordinary Shares For Resale By Selling Shareholder - SEC Filing
Brief: Qtrex Expands Into Quantum Processor Interface With Single-Build Cryogenic Chip Carrier
NASDAQ RESUMED AT 11:03 AM